Takasaki, Japan

Nobuhito Kashiwagi


 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1996-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nobuhito Kashiwagi: Innovator in Medical Treatments

Introduction

Nobuhito Kashiwagi is a notable inventor based in Takasaki, Japan. He has made significant contributions to the field of medical treatments, particularly in the area of inflammatory diseases and anti-drug antibody measurement. With a total of two patents to his name, his work has the potential to improve patient care and treatment outcomes.

Latest Patents

Kashiwagi's latest patents include a "Method for measuring anti-drug antibody" and a "Method of treating inflammatory diseases." The first patent provides a simpler and more accurate method for measuring anti-drug antibodies (ADAs) in patients undergoing molecular-targeted therapy. The second patent outlines a method for treating inflammatory diseases by contacting a patient's peripheral blood with a carrier that has a higher affinity for inflammation-associated cells than for lymphocytes. This innovative approach allows for prompt treatment of inflammatory diseases without the need for drug therapy, thereby minimizing adverse side effects for patients.

Career Highlights

Throughout his career, Kashiwagi has worked with prominent companies such as Japan Immunoresearch Laboratories Co., Ltd. and Sekisui Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in medical research and innovation.

Collaborations

Kashiwagi has collaborated with notable colleagues, including Syojiroh Asakura and Tatsuo Ide. Their combined efforts have further advanced the research and development of effective medical treatments.

Conclusion

Nobuhito Kashiwagi's contributions to medical innovation, particularly in the treatment of inflammatory diseases and the measurement of anti-drug antibodies, highlight his importance in the field. His work continues to pave the way for improved patient care and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…